Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LuAF-82422 by H. Lundbeck for Parkinson's Disease: Likelihood of Approval
LuAF-82422 is under clinical development by H. Lundbeck and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase...
Data Insights
LuAF-82422 by H. Lundbeck for Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration): Likelihood of Approval
LuAF-82422 is under clinical development by H. Lundbeck and currently in Phase II for Multiple System Atrophy (MSA or Shy-Drager...